Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians
Thieme-Praxis-Report. Geburtshilfe und Frauenheilkunde/Geburtshilfe und Frauenheilkunde